Healthcare AI Governance Fails When Systems Run Faster Than Oversight

Healthcare AI Governance Fails When Systems Run Faster Than Oversight

Healthcare has seen this pattern before: new technology arrives, deployment races ahead of integration, and accountability gaps close only after incidents force regulatory action. Artificial intelligence is following the same trajectory, but faster and at larger scale, inside systems that were already strained.

The harder question isn't what AI is doing to healthcare—it's what healthcare institutions were never designed to be. Organizations now deploying agentic AI were built for different tools, different workflows, and different risk profiles. According to analysis published by Acuvera co-founders Anca del Río and Tyson Welzel, the challenge ahead isn't fixing existing systems but designing new ones from scratch.

The governance blind spot

Traditional clinical workflows follow clear chains: a clinician orders, documents, and signs. Agentic AI systems initiate actions, sequence decisions, and operate across departmental boundaries simultaneously. They don't wait for explicit workflow invitations and don't produce single, traceable decision points. Instead, they generate distributed effects across pathways and patient records that no existing governance structure was designed to follow.

Patient safety frameworks have long understood that error is a system property, not a personal failing. The architecture of clinical risk management assumes humans remain visible in the causal chain—interruptible and ultimately accountable. Agentic AI inverts that assumption. The question shifts from what happens when humans err to what happens when machines err, or when interface design makes human error structurally inevitable.

This isn't a technology problem layered onto an organizational one. It's a categorical mismatch between tool architecture and institutional architecture, regardless of whether systems are fully autonomous, semi-autonomous, or explicitly constrained.

Human-on-the-loop isn't human-in-the-loop

Consider a scenario the authors describe: A covering physician reviews 41 prescribing actions from an overnight medicines-optimization system. Each carries a green confidence marker and a single "Approve" button. The underlying reasoning sits two clicks away, behind data the physician lacks time to reconstruct. She clears the queue in under four minutes because the round is moving and the system has been correct for six months. One action continues an anticoagulant at a dose inferred from outdated weight data. No one re-derives it because the interface was built to be cleared, not interrogated. The approval is recorded against her registration number.

This is the design working as intended. Systems now run human-on-the-loop—clinicians monitor but don't gate each action—while regulatory frameworks still assume human-in-the-loop, placing responsibility on individuals presumed to have authorized each act. When rare errors surface, liability falls on the out-of-the-loop reviewer whom low error rates have made least vigilant.

In May 2024, Sir Geoffrey Vos framed the dilemma from the bench: a professional may be negligent for using AI and negligent for declining to use it. The EU AI Act requires human override capability as a legal standard, but workflows have designed that capability out. When controls can't be exercised, failure defaults to the clinician—what legal and clinical scholarship calls the liability sink.

Procurement doesn't enforce what regulation requires

The EU AI Act classifies healthcare AI systems as high-risk under Annex III. Article 14 mandates that such systems enable effective human oversight, including explicit ability to override or reverse outputs. The regulation entered force in 2024. Yet procurement frameworks at facility level don't require Article 14 compliance as a purchase condition.

AI systems are acquired by multiple stakeholders—CIOs, CDOs, clinical leads—each with authority over a fragment of the problem, rarely in consultation with legal, clinical risk, information security, or patient safety functions. The regulation sets a standard; the purchase order doesn't enforce it. Staff education and process redesign must precede deployment, but neither is currently a procurement requirement.

Operational AI scales faster than clinical AI because its ROI is clear and its liability lower. Efficiency gains accumulate before the accountability architecture problem surfaces. When no governance layer is designed into deployment, accountability concentrates on the clinician at the checkpoint, the institution in regulatory filings, and the patient in outcomes.

Why it matters

This isn't a policy failure that negotiation can resolve—it's an architecture failure that requires redesign. Healthcare institutions need procurement criteria, accountability mapping, and governance structures built into AI deployment from the start, not appended after incidents. Without that foundation, the gap between what AI systems can do and who answers when they fail will only widen, putting both clinicians and patients at structural risk.

The analysis was published by Anca del Río and Tyson Welzel of Acuvera and presented at HLTH Europe, where details were first reported.